BFC Planning »

Vaneck Vectors Pharmaceutical etf shares owned by BFC Planning

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by BFC Planning from 13F filings

Historical chart of BFC Planning investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by BFC Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by BFC Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $125k 1.1k 109.35
2026-03-31 $103k 989 103.86
2025-12-31 $75k 722 103.14
2025-09-30 $64k 709 90.32
2025-06-30 $62k 702 87.94
2025-03-31 $17k 189 90.99
2024-12-31 $15k 174 86.13

More positions owned by BFC Planning

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust ST STR PR SP1500 (SPTM)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)

View all positions for BFC Planning

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
UBS Group
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
J.Safra Asset Management
Susquehanna International
Avalon Trust
LPL Financial
Citigroup
Adamsbrown Wealth Consultants
Miller Investment Management
Royal Bank of Canada
Bank of America Corporation
Old National Trust Company
Rye Brook Capital

View all funds holding Vaneck Vectors Pharmaceutical etf